Study of the Long-Term Outcomes of Posterior Spinal Fixation With the Karma Device

Lumbar Disc Disease Clinical Trial

Official title:

CORTI-FIX: Clinical and Radiographic Outcomes Following Lumbar Interbody Placement With Posterior Minimally Invasive Intra-Laminar PEEK Ratcheting Fixation Device

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04984213
• Other study ID #: SEI-004
• Status: Not yet recruiting
• Start date: August 15, 2021
• Est. completion date: December 31, 2024

Study information

• Verified date: July 2021
• Source: Spinal Elements
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The primary objective of this clinical study is to measure fusion rate in patients at 12 months following lumbar fusion in combination with posterior fixation using the Karma® device.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: December 31, 2024
• Est. primary completion date: December 31, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Skeletally mature and age = 18 years of age

2. Appropriate patient as determined by the Investigator for anterior or lateral approach to lumbar interbody fusion surgery with planned posterior fixation to treat degenerative disc disease in one or two adjacent vertebral levels between L2 and S1.

3. Failed at least six months of conservative treatment. This may or may not include any of the following,

1. Spinal injections

2. Chiropractic care

3. Physical therapy

4. Activity modification and/or with anti-inflammatory medications

4. Oswestry Low Back Pain Disability Questionnaire score of at least 30%

5. Visual Analog Scale (VAS) for back/hip/lower extremity pain ranking at a minimum at least 3/10 (30%)

6. Psychosocially, mentally and physically able to fully comply with this protocol including adhering to follow-up schedule, study requirements with a signed informed consent with a study collaborator present at the time of signing to ensure compliance.

Exclusion Criteria:

1. Patients with greater than two levels of degenerative disease or deformity for INTENDED operative levels.

2. Previous fusion or total disc replacement at the intended level/s

3. Known allergy to implant and instrument materials

4. Clinically compromised vertebral bodies at the affected level(s) due to current or past trauma

5. Degenerative spondylolisthesis of grade >2

6. Isthmic spondylolisthesis

7. Back or leg pain of unknown etiology

8. Active systemic infection or infection at the location planned surgery

9. Active or suspected malignancy. If symptom free for 2 years, patients with prior malignancy may be included.

10. Morbid obesity defined as a body mass index > 40

11. Patient being treated for other specific medical conditions that may affect bone density or the ability to obtain fusion (ie: steroids, etc)

12. Pregnant or have plans to become pregnant in the next year.

13. Currently a prisoner

14. Patient has any condition, that in the opinion of the Investigator, would prohibit the patient from complying with the protocol

15. Participation in a concurrent clinical study.

Related Conditions & MeSH terms

• Lumbar Disc Disease

Intervention

Device:
• Karma Posterior Fixation Device
Posterior Fixation

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Spinal Elements

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Fusion Rate	Interbody Fusion Rate	12 months